Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOX Preoperative Chemotherapy in Gastric Cancer
NCT01672333Phase 2Completed
- Sponsor
- Milad Hospital
- Start
- Jun 2008
- Primary completion
- Mar 2011
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin, capecitabine in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Milad Hospital. Started Jun 2008; status: completed.
02
Drugs
docetaxeloxaliplatincapecitabine
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01672333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01672333.